Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP399555.RAlfQUlitZSgLwEDl6r4MzHhuanMQ57H7QUwpMCB8AAUE130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399555.RAlfQUlitZSgLwEDl6r4MzHhuanMQ57H7QUwpMCB8AAUE130_provenance.
• assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP434076.RAF_E1sTUB7Y1ADp-ZmMMiqTeRqk3mQ0zyMa5VJv8bpjA130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434076.RAF_E1sTUB7Y1ADp-ZmMMiqTeRqk3mQ0zyMa5VJv8bpjA130_provenance.
• NP877980.RA21iaeqLa9Glqdyz8l3ggMKnv_kJuVv4x2mgljZeuYWk130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877980.RA21iaeqLa9Glqdyz8l3ggMKnv_kJuVv4x2mgljZeuYWk130_provenance.
• NP567916.RAIlNzGEr0wIWRVCrzENGv7WX-EJJLg11iZm9yWs3kn2M130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567916.RAIlNzGEr0wIWRVCrzENGv7WX-EJJLg11iZm9yWs3kn2M130_provenance.
• assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP547156.RAftUJxqulE_Y9K25rq1k4TAns9GALqaQHJT-mLovCk5M130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547156.RAftUJxqulE_Y9K25rq1k4TAns9GALqaQHJT-mLovCk5M130_provenance.
• NP547155.RAru9-iyf2LH7V1nJK_GIqo2OBEqvzQmyNvX8xvgT2DvY130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547155.RAru9-iyf2LH7V1nJK_GIqo2OBEqvzQmyNvX8xvgT2DvY130_provenance.
• NP631602.RAGPf2sz2t61i6FjMQ9MKccH2SrZyDVV-QFd9x_JCT-LM130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631602.RAGPf2sz2t61i6FjMQ9MKccH2SrZyDVV-QFd9x_JCT-LM130_provenance.
• NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
• NP547157.RAKfhrmIHAg7ug_TKReL6xhIQ3vCWwVO4gG8A1iFREZoI130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547157.RAKfhrmIHAg7ug_TKReL6xhIQ3vCWwVO4gG8A1iFREZoI130_provenance.
• NP547158.RAONtr7aUrNdAx80ZNmckcS2gwL42eyJ8XtGpYv04Kzfc130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547158.RAONtr7aUrNdAx80ZNmckcS2gwL42eyJ8XtGpYv04Kzfc130_provenance.